Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 15.3 | pmol/sample |
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 19.2 | pmol/sample |
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 20.8 | pmol/sample |
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 14.8 | pmol/sample |
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 11.5 | pmol/sample |
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 15.5 | pmol/sample |
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 13.9 | pmol/sample |
| LMST01010017 | Lanosterol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 7.78 | pmol/sample |
| LMST01010017 | Lanosterol | C | 0.0 | BCD100322A01 | 76.2 | pmol/sample |
| LMST01010017 | Lanosterol | C | 0.5 | BCD100322A03 | 47.5 | pmol/sample |
| LMST01010017 | Lanosterol | C | 1.0 | BCD100322A07 | 76.9 | pmol/sample |
| LMST01010017 | Lanosterol | C | 2.0 | BCD100322A11 | 82 | pmol/sample |
| LMST01010017 | Lanosterol | C | 4.0 | BCD100322A15 | 97.6 | pmol/sample |
| LMST01010017 | Lanosterol | C | 8.0 | BCD100322A19 | 148 | pmol/sample |
| LMST01010017 | Lanosterol | C | 12.0 | BCD100322A23 | 90.9 | pmol/sample |
| LMST01010017 | Lanosterol | C | 24.0 | BCD100322A27 | 65.1 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 18.1 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 18.3 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 10.7 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 11.6 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 18 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 18.8 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 27.1 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol | 0.5 | BCD100322A04 | 97.4 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol | 1.0 | BCD100322A08 | 68.8 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol | 2.0 | BCD100322A12 | 71 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol | 4.0 | BCD100322A16 | 33.6 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol | 8.0 | BCD100322A20 | 32.2 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol | 12.0 | BCD100322A24 | 38.5 | pmol/sample |
| LMST01010017 | Lanosterol | 25OH-Chol | 24.0 | BCD100322A28 | 18.6 | pmol/sample |